Innovus (INNV) Brings Leading Nasal Steroid from Rx to OTC
Innovus Pharmaceuticals Inc. (OTCQB:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative, and effective over-the-counter medicine and consumer care products, plans to launch a new product into a multibillion dollar market in the near-term. After acquiring over-the-counter rights to FlutiCare™ - a leading prescription nasal steroid – in February 2015, the company expects to receive regulatory approval later this year.
View full press release